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Summary: A radioimmunoassay (RIA) is described for the measurement of llß,17ß-dihydroxy-4-androsten-
3-one (llß-hydroxytestosterone) in human plasma. The reliability criteria of the new RIA were similar to
those of other steroid hormone radioimmunoassays. The mean plasma llß,17ß-dihydroxy-4-androsten-3-one
level for healthy young subjects was 1.31 ± 0.32 nmol/1 (x ± SD) in males and 1.19 ± 0.35 nmol/1 in females
at 8 a. m.; during the night, there was a marked decrease, and at 11 p. m. the recorded values were 0.41 ±
0.15 nmol/1 and 0.46 ± 0.14 nmol/1, respectively. During the corticotropin Stimulation test, llß,17ß-
dihydroxy-4-androsten-3-one increased from 1.03 ± 0.33 nmol/1 to 1.31 ± 0.41 nmol/1, while in dexametha-
sone suppression tests a decrease from 2.04 ± 0.82 nmol/1 to 0.25 ± 0.05 nmol/1 was seen. In contrast,
| chorionic gonadotropin administration on 3 consecutive days did not influence plasma concentrations of
f 11 ß,17ß-dihydroxy-4-androsten-3-one.
Radioimmunoassay zur Messung von llßf i7ß-Dihydroxy-4-androsten-3-on (llß-Hydroxytestosteron) im
Plasma des Menschen
Zusammenfassung: Es wird ein Radioimmunoassay für die Messung von llß,17ß-Dihydroxy-4-androsten-3-
on (llß-Hydroxytestosteron) im menschlichen Plasma beschrieben. Die Zuverlässigkeitskriterien des neu
aufgebauten RIA entsprechen denen anderer Radioimmunoassays für Steroidhormone.
Die Konzentration von llß,17ß-Dihydroxy-4-androsten-3-on betrug um 8.00 Uhr im Plasma gesunder
Männer 1,31 + 0,32 nmol/1 ( ± SD) und bei gesunden Frauen 1,19 ± 0,35 nmol/1. Um 23.00 Uhr fanden
; sich 0,41 ± 0,15 nmol/1 (Männer) und 0,46 ± 0,14 nmol/1 (Frauen). Im Cörticotropin-Stimulationstest war
ein Anstieg der Konzentration von llß,17ß-Dihydroxy-4-androsten-3-on im Plasma von 1,03 ± 0,33 nmol/1
| auf 1,31 ± 0,41 nmol/1 zu beobachten, während sich im Dexamethasontest ein Rückgang von 2,04 ± 0,82
! nmol/1 auf 0,25 ± 0,05 nmol/1 ergab. Nach Applikation von Choriongonadotropin wurde keine Änderung
i der Konzentration von llß,17ß-Dihydroxy-4-androsten-3-on gemessen.
Introduction Recently 17ß-hydroxy-4-androstene-3,ll-dione and
The adrenal atidrogens are quantitatively the most 4-androstene-3, 11,17-trione were demonstrated in
important steroid hormones but their physiological human plasma (2, 3). In contrast, no Information
role reniains still somewhat obscure in man. Far less is ayailable about llß,17ß-dihydroxy-4-androsten-3-
information is available about the adrenal androgens one in human peripheral blood. The present paper
that carry a functional group at C-ll. llß-Hydroxy- describes a radioimmunoassay system for the meas-
4-androstene-3,17-dione has been demonstrated in urement of llß,17ß-dihydroxy-4-androsten-3-one,
human plasma and might play an important role and presents the fürst published values for this andro-
under physiological and pathological conditions (1). gen in human plasma.
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Materials and Methods
Steroids and reagents
Non-radioactive and radioactive steroids ([l,2-3H]cortisol,
1.5-2.2 TBq/mol) were obtained from Sigma, Taufkirchen,
and New England Nuclear, Dreieich, respectively. [1,2-
3H]11 ß,l 7ß-Dihydroxy-4-androsten-3-one was synthesized
from [l,2-3H]cortisol, by a method similar to that described in
a previous paper (2), following the procedure of Appleby &
Norymberski (4). All organic solvents (Merck, Darmstadt, ana-
lytical grade) were used without further purification. Sodium
phosphate buffer (0.15 mol/1, pH 7.0) containing l g/l gelatin
served äs assay buffer. Charcoal (l g) and Dextran T70 (0.1 g)
were suspended in 100 ml assay buffer. Bovine serum albumin
was obtained from Merck. UV-spectra were taken with a Zeiss-
spectrometer. Univsolve (Zinsser, Frankfurt) was used äs scin-
tillation mixture. Tritium radioactivity was measured in a liquid
scintillation spectrometer (Packard, Frankfurt).
tion of 0.25 mg Synacthen (CIBA, Basel) in 9 healthy male
volunteers. Blood was taken immediately before and l h after
Stimulation. Dexamethasone (3mg, orally) was applied for
adrenal suppression at 11 p. m. to 10 healthy female subjects.
Blood samples were taken at 8 a. m. on the day of dexametha-
sone application and at 8 a. m. the $ay thereafter. Testicular
Stimulation was performed in 7 healthy male subjects äs de-
scribed previously (8). On the first and fourth day plasma was
collected at 8 a. m. and 7 p. m., and on the first, second and
third day 5000 I. U. human chorionic gonadotropin were ad-
ministered i. m. at 7 p. m.
Statistics
Hormone concentrations were given äs the mean ± Standard
deviation ( ± SD). Data were processed statistically using the
Wilcoxon rank test.
llß,17ß-Dihydroxy-4-androsten-3-one antiserum
11 ß,l 7ß-Dihydroxy-4-androsten-3-one 3-(O-carboxymethyl)
oxime bovine serum albumin conjugate was prepared according
to Erlanger et al. (5). The antigen was used to generate the
antiserum in female rabbits. The working dilution of antiserum
used in the radioimmunoassay was l : 20 000. Sera were stored
at -35°C.
Plasma extraction and chromatography
Plasma samples (1.0 ml) were mixed with labeled llß,17ß-
dihydroxy-4-androsten-3-one (1500 counts/min) and allowed
to equilibrate for 15 min at room temperature. Steroids were
extracted with diethylether (5 ml). The solvent was removed by
evaporation under a gentle stream of nitrogen and the residue
was purified by thin-layer chromatography (Merck Silica 60 F
254; cyclohexane/ethyl acetate, 50 + 50 by vol.). llß,17ß-
Dihydroxy-4-androsten-3-one was located from the position of
chromatographed non-radioactive llß,17ß-dihydrox-4-andros-
ten-3-one (detected by UV), and by beta-scanning of the spot.
Radioimmunoassay
The methanolic eluates of the thin-layer chromatograms, con-
taining llß,17ß-dihydroxy-4-androsten-3-one, were evaporated
under a stream of nitrogen, and the dry residues dissölved in
assay buffer (0.5 ml). Duplicates of 0.10 ml were used for
radioimmunoassay and a 0.20 ml sample was taken for the
measurement of procedural loss after evaporation of the sol-
vent. To each tube (unknown samples and Standards) were
added [l ,2-3H]11 ß, l7ß-dihydroxy-4-androsten-3-one (about
8000 counts/min) in 0.05 ml and diluted antiserum (0.20 ml).
After incubation at 4 °C overnight, a charcoal Suspension (0.5
ml) was added to each tube. The tubes were vortexed and after
a 10 min incubation period at 4 °C they were centrifuged at
1500 g for 10 min. Aliquots of the supernatants were placed in
counting vials containing 10ml scintillation fluid. The proce-
dures for the measurement of Cortisol (6) and testosterone (7)
were described previously.
Experimental conditions
llß,17ß-Dihydroxy-4-androsten-3-one was measured in the
plasma of healthy male (n = 21) and female (n = 21) subjects
(20-40 years of age) at 8 a. m. and 11 p.m. Corticotropin
Stimulation of the adrenal gland was carried out by i. v. injec-
Tab. 1. Cross reactivities of difFerent steroids with the anti-
serum to llß,17ß-dihydroxy-4-androsten-3-one.
Steroid Reactivity%>
11 ß, 17ß-Dihydroxy-4^androsten-3rpne 100.00
(l l ß-hydroxy testosterone)
17ß-Hydroxy-5a-androstan-3-one 0.44
(5a-dihydrotestosterone)
17ß-Hydroxy-4-androstene-3,ll-dione 0.34
(11 -oxotestosterone)
17ß-Hydroxy-4-androsten-3-one 0.20
(testosterone)
17a,21 -Dihydroxy-4-pregnene-3,11,20-trione 0.15
(cortisone)
llß,17a,21-Trihydroxy-4-pregri'ene-3,20-dione 0.14
(cortisol)
llß-Hydroxy-4-androstene-3,17-dione < 0.10
(l l ß-hydroxyandrostendione)
4-Androstene-3,ll,17-trione < 0.10
(l 1-oxoandrostendione)
4-Androstene-3,17-diqne < 0.10
(androstendione)
3a-Hydroxy-5c^androstan^l7-one < 0.10
(androsterone)
4-Pregnene-3,20-dione < 0.10
(prögesterone)
17-Hydroxy-4-pregnene-3,20-dione . < 0.10
(l 7-hydf oxyprogesterone)
3ß-Hydroxy-5-pregnen-2Ö-one < 0.10
(pregnenolone)
3-Hydroxy-l,3,5(10)-oestratrien-17-one < 0.10
(oestrone)
l,3,5(10)-Oestratriene-3,16a,17ß-triol < 0.10
(oestriol)
l,3,5(10)-Oestratriene-3,17ß-diol < 0.10
(oestradiol-17ß)
3,20-Dioxo-llß-21-dihydroxy-4-pregnen-18-al < 0.10(aldosterone)
9-Flüoro.l6a-methyl-llß,17,21-trihyaroxy- < 0.10
l,4-pregiiadiene-3,20-dione (dexamethasone)
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Results
Specificity
The specificity of the* antiserum was determined by
incubation of constant amounts of antiserum and
labelled antigen with varying amounts of cross-react-
ing steroids (tab. 1). The highest cross-reaction was
0.44%.
Imprecision
The intra-assay coefficient of Variation was 7.2%
(n = 25) and the inter-assay coefficient of Variation
was 9.6% (n = 25).
male plasma were heated for l h at 70 °C, and cleared
of endogenous steroids by charcoal adsorption. To
these plasma samples 0.045, 0.15 or 0.30 pmol
11 ß, l7ß-dihydroxy-4-androsten-3-one were added.
The samples were processed äs usual. Comparison of
the expected amounts determined in the described
radioimmunoassay gave a correlation coefficient of
r = 0.993. Furthermore, the accuracy of the RIA
was checked against gas chromatography/mass spec-
trometry. The difference between l lß,17ß-dihydroxy-
4-androsten-3-one concentrations in a given sample
of pool plasma measüred by RIA (0.295 nmol/1) or
by the physico-chemical method (0.309 nmol/1) was
about 5%.
Sensitivity
The lower assay detection limit was estimated using
the formula of Abraham (9). The blank values for
11 ß,l 7ß-dihydroxy-4-androsten-3-one were 0.010
pmol per tube. Significant differences from zero va-
lues were obtained starting with 0.016 pmol. After
semilogarithmic transformation the Standard curves
showed linearity from 0.033 to 0.657 pmol.
Recovery
The average recovery of added [l,2-3H]llß,17ß-dihy-
droxy-4-androsten-3-one from 92 plasma samples
was 78.5 + 4.1%. All hormone concentrations given
are corrected for procedural loss using an internal
Standard for each sample. Aliquots (l ml) of pooled
Plasma concentrations of l lß,17ß-dihydr-
oxy-4-androsten-3-one
The mean 11 ß,17ß-dihydroxy-4-androsten-3-one
serum concentration was found to be 1.31 ± 0.32
nmol/1 in male and 1.19 ± 0.35 nmol/1 in female
young subjects at 8 a. m. Concomitantly with Cortisol,
llß,17ß-dihydroxy-4-androsten-3-one decreased dur-
ing the night, giving at 11 p. m. 0.41 + 0.15 nmol/1
in males and 0.46 ± 0.14 nmol/1 in females (tab. 2).
Sex differences in plasma concentrations of llß,17ß-
dihydroxy-4-androsten-3-one were not significant.
During adrenal cortex Stimulation by corticotropin,
Cortisol increased 3.2-fold l h after corticotropin ad-
ministration (tab. 3), while llß,17ß-dihydroxy-4-an-
drosten-3-one increased l .3-fold l h after corticotro-
pin administration. Dexamethasone suppression of
Tab. 2. Diurnal Variation of plasma Cortisol and llß,17ß^dihydroxy-4-androsten-3-one (nmol/1) in healthy subjects, 20—40 years
of age.
Males Females
(n = 21) (n = 21)
8 a.m. 11 p.m. p 8 a.m. 11 p.m. p
Cortisol
llß,17ß-Dihydroxy-
4-andcosten-3-one
277.95 ± 59.23 61.20 ± 59.82 <0.01
1.31 ± 0.32 0.41 ± 0.15 <0.01
429.97 ± 190.99 112.64 ± 91.77 <0.01
1.19 ± 0.35 0.46 ± 0.14 <0.01
To obtain [ng/ml] multiply by 0.362 (cortisol) or 0.304 (llß,17ß-dihydroxy-4-androsten-3-one).
Tab. 3. Plasma cortisol and llß,17ß-dihydroxy-4-androsten-3-one (nmol/1) before and after corticotropin Stimulation in healthy
males, 20—40 years of age. Blood was drawn at 8 a.m. and l h after injection of 0.25 mg synacthen.
Before corticotropin
(n
After corticotropin
(n = 9)
Cortisol
1 1 ß,l 7ß-Dihydroxy-4-androsten-3-one
B
201.94 ± 43.24
1.03 ± 0.33
A
658.37 ± 89.38
1.31 ± 0.41
A/B
3.26
1.27
P
<0.01
<0.01
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Tab. 4. Plasma Cortisol and 11 ß,17ß-dihydroxy-4-androsten-3-one (nmol/1) before and after adrenal suppression by dexamethasone
in healthy females, 20—40 years of age. Blood was drawn at 8 a.m. before and at 8 a.m. after dexamethasone application
(at 11 p.m., orally).
Before dexamethasone
(n = 10)
After dexamethasone
(n i 10)
Cortisol
1 1 ß,l 7ß-Dihydroxy-4-androsten-3-one
B
279.39 + 59.39
2.04 ± 0.82
A
6.82 + 3.77
0.25 ± 0.05
A/B
0.024
0.122
P
<0.01
<0.01
Tab. 5. Plasma testosterone and llß^ß-dihydroxy^-androsten-S^one (nmol/1) before and after chorionic gönadötropin Stimula-
tion in 7 healthy male subjects. 5000 I.U. chorionic gonadotropin were given i.m. on 3 consecutive days at 7 p.m. Blood
was drawn on the first and the fourth day. Data represent the mean of the two samples of each day.
Before
chorionic gonadotropin
(n = 7)
B
After
chorionic gonadotropin
(n = 7)
A/B
Testosterone
11 ß,l 7ß-Dihydroxy-4-androsten-3-one
18.92 ± 6.78
1.23 ± 0.34
37.95 ± 10.87
1.14 ± 0.26
2.01
0.26
<0.02
n.s.
To obtain [ng/ml] multiply by 0.288 (testosterone) or 0.304 (llß,17ß-dihydroxy-4-androsten-3-one).
the adrenal gland caused substantial decreases in
the plasma concentrations of Cortisol and llß,17ß-
dihydroxy-4-androsten-3-one (tab. 4). llß,17ß-Dihy-
droxy-4-androsten-3-one decreased by 88% (from
2.04 ± 0.82 nmol/1 to 0.25 ± 0.05 nmol/1). Human
chorionic gonadotropin Stimulation of the testes over
a period of 3 days in 7 male volunteers resulted in
a 2-fold increase in testosterone. Plasma llß,17ß-
dihydroxy-4-androsten-3-one, however, remained un-
affected (tab. 5).
Discussion
In the present paper, a radioimmunoassay (RIA) for
the determination of 11 ß,17ß-dihydroxy-4-androsten-
3-one in human plasma is described. The antiserum
was of high specificity (tab. 1); the maximal cross-
reaction with other steroids was less than 0.5%. Be-
cause we were the first to measure llß,17ß-dihydr-
oxy-4-androsten-3-one in human plasma, we used
thin layer chromatography to minimize unspecific
effects, and we monitored the RIA by gas chromatog-
raphy/mass spectrometry. The two methods gave
nearly identical results when measuring plasma con-
centrations of a plasma pool. Our data demonstrate
that llß,17ß-dihydroxy-4-androsten-3-one is present
in the plasma of male and female subjects. The ränge
of plasma concentration (about 1.25 nmol/1) is com-
parable with that of 17ß-hydroxy-5a-androstan-3-one
(10). However, in contrast to other C^ steroids, no
significant sex difference could be found in the
11 ß,l 7ß-dihydroxy-4-androsten-3-one plasma con-
centration. Furthermore, it was demonstrated that
the llß,17ß-dihydroxy-4-androsten-3-one concentra-
tion is substantially higher in the morning (tab. 2)
than in the evening, suggesting a circadian rhythm.
Adrenal Stimulation by corticotröpin resulted in a
small but significant increase in llß,17ß-dihydroxy-
4-androsten-3-one (tab. 3«), whereas gonadal Stimula-
tion by human chorionic gonadotropin had no effect
(tab. 5). Moreover, it was shown that dexamethasone
suppression of the adrenal gland lowered llß,17ß-
dihydroxy-4-androsten-3-one levels significantly.
Thus from these experiments it appears most likely
that llß,17ß,dihydrQxy-4-androsten-3-pne is mainly
a secretory product of the adrenal gland, and that
this steroid is a specific marker of adrenal functiori.
Furthermore, 11 ß,l 7ß-dihydroxy-4-androsten-3-one
might be of interest in regard to the autoregulation
of steroidögenesis in the adrenal gland by modifyirig
enzyme activities (11, 12).
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